Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Gilead Sciences
Gilead Sciences
Autolus Limited
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.
Novartis
Duke University
Kura Oncology, Inc.
University of Texas Southwestern Medical Center
AbbVie
Novartis
UNC Lineberger Comprehensive Cancer Center
Jazz Pharmaceuticals
University of California, San Francisco
ERYtech Pharma
Barbara Ann Karmanos Cancer Institute